{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:28:35Z","timestamp":1790256515132,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ijbiomac.2020.02.287","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T11:47:41Z","timestamp":1582804061000},"page":"904-912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"C","title":["Alginate-coated chitosan nanoparticles act as effective adjuvant for hepatitis A vaccine in mice"],"prefix":"10.1016","volume":"152","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7058-2649","authenticated-orcid":false,"given":"Nourhan H.","family":"AbdelAllah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2244-4406","authenticated-orcid":false,"given":"Yasser","family":"Gaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2877-9418","authenticated-orcid":false,"given":"Mohamed E.","family":"Rashed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7347-9564","authenticated-orcid":false,"given":"Ahmed F.","family":"Azmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7655-2088","authenticated-orcid":false,"given":"Heba A.","family":"Abou-Taleb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3999-2839","authenticated-orcid":false,"given":"Sameh","family":"AbdelGhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2020.02.287_bb0005","author":"Medicine"},{"key":"10.1016\/j.ijbiomac.2020.02.287_bb0010","author":"CDC, Centers for Disease Control and Prevention (CDC)"},{"key":"10.1016\/j.ijbiomac.2020.02.287_bb0015","series-title":"Hepatitis A\/Fact Sheet","author":"WHO, World Health Organization (WHO)","year":"2019"},{"issue":"41","key":"10.1016\/j.ijbiomac.2020.02.287_bb0020","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1016\/j.vaccine.2010.08.037","article-title":"Hepatitis A virus seroprevalence by age and world region, 1990 and 2005","volume":"28","author":"Jacobsen","year":"2010","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.02.287_bb0025","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1128\/CMR.14.1.38-58.2001","article-title":"Hepatitis A: old and new","volume":"14","author":"Cuthbert","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijbiomac.2020.02.287_bb0030","series-title":"Hepatitis A","author":"Canadian Centre for Occupational Health and Safety (CCOHS)","year":"2019"},{"key":"10.1016\/j.ijbiomac.2020.02.287_bb0035","series-title":"Hepatitis A Vaccine","author":"WHO, World Health Organization (WHO)","year":"2019"},{"issue":"3","key":"10.1016\/j.ijbiomac.2020.02.287_bb0040","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/hep.510270336","article-title":"Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease","volume":"27","author":"Keeffe","year":"1998","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.02.287_bb0045","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/(SICI)1096-9071(199706)52:2<215::AID-JMV16>3.0.CO;2-J","article-title":"Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease","volume":"52","author":"Lee","year":"1997","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.02.287_bb0050","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/jmv.1890460109","article-title":"Immunogenicity and safety of an inactivated hepatitis A vaccine in anti-HIV positive and negative homosexual men","volume":"46","author":"Hess","year":"1995","journal-title":"J. Med. Virol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.02.287_bb0055","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1086\/516512","article-title":"Response to hepatitis A vaccination in human immunodeficiency virus-infected and -uninfected homosexual men","volume":"176","author":"Neilsen","year":"1997","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.ijbiomac.2020.02.287_bb0060","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/brain\/124.9.1821","article-title":"Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle","volume":"124","author":"Gherardi","year":"2001","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.ijbiomac.2020.02.287_bb0065","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.0818-9641.2004.01286.x","article-title":"Aluminium compounds for use in vaccines","volume":"82","author":"Lindblad","year":"2004","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2020.02.287_bb0070","series-title":"Aluminium Salts: Perspectives in Their Use as Adjuvants\u2014Bookmetrix Analysis","author":"Bomford","year":"1989"},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.02.287_bb0075","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1128\/iai.65.2.623-629.1997","article-title":"Adjuvant modulation of immune responses to tuberculosis subunit vaccines","volume":"65","author":"Lindblad","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijbiomac.2020.02.287_bb0080","doi-asserted-by":"crossref","first-page":"7659684","DOI":"10.1155\/2016\/7659684","article-title":"Chitosan and sodium alginate combinations are alternative, efficient, and safe natural adjuvant systems for hepatitis B vaccine in mouse model","volume":"2016","author":"AbdelAllah","year":"2016","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"3","key":"10.1016\/j.ijbiomac.2020.02.287_bb0085","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.biomaterials.2010.09.058","article-title":"In vivo efficacy of a chitosan\/IL-12 adjuvant system for protein-based vaccines","volume":"32","author":"Heffernan","year":"2011","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.ijbiomac.2020.02.287_bb0090","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/1389201033489748","article-title":"Application of chitin and chitosan derivatives in the pharmaceutical field","volume":"4","author":"Kato","year":"2003","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"42","key":"10.1016\/j.ijbiomac.2020.02.287_bb0095","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1016\/j.vaccine.2013.07.081","article-title":"In vivo evaluation of chitosan as an adjuvant in subcutaneous vaccine formulations","volume":"31","author":"Scherliess","year":"2013","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.02.287_bb0100","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ejpb.2008.01.019","article-title":"Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles","volume":"69","author":"Borges","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"13\u201314","key":"10.1016\/j.ijbiomac.2020.02.287_bb0105","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.intimp.2008.08.013","article-title":"Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen","volume":"8","author":"Borges","year":"2008","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2020.02.287_bb0110","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1021\/am501337s","article-title":"Effect of pH-responsive alginate\/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers","volume":"6","author":"Feng","year":"2014","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"33","key":"10.1016\/j.ijbiomac.2020.02.287_bb0115","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.1016\/j.vaccine.2018.05.087","article-title":"Chitosan\/alginate microparticles for the oral delivery of fowl typhoid vaccine: innate and acquired immunity","volume":"36","author":"Onuigbo","year":"2018","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.ijbiomac.2020.02.287_bb0120","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.vaccine.2017.01.067","article-title":"Omp16-based vaccine encapsulated by alginate-chitosan microspheres provides significant protection against Haemophilus parasuis in mice","volume":"35","author":"Zheng","year":"2017","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.02.287_bb0125","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.fsi.2015.05.045","article-title":"An oral DNA vaccine against infectious haematopoietic necrosis virus (IHNV) encapsulated in alginate microspheres induces dose-dependent immune responses and significant protection in rainbow trout (Oncorrhynchus mykiss)","volume":"45","author":"Ballesteros","year":"2015","journal-title":"Fish & Shellfish Immunology"},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.02.287_bb0130","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejps.2007.08.005","article-title":"Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles","volume":"32","author":"Borges","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2020.02.287_bb0135","series-title":"AVMA Guidelines for the Euthanasia of Animals: 2013 Edition","author":"Leary","year":"2013"},{"key":"10.1016\/j.ijbiomac.2020.02.287_bb0140","first-page":"262","article-title":"European Pharmacopoeia (Ph. Eur.)","volume":"1","author":"European Pharmacopoeia Commission, and European Directorate for the Quality of Medicines & Healthcare","year":"2017"},{"issue":"3","key":"10.1016\/j.ijbiomac.2020.02.287_bb0145","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints12","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.02.287_bb0150","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2005.04.037","article-title":"Preparation of coated nanoparticles for a new mucosal vaccine delivery system","volume":"299","author":"Borges","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2020.02.287_bb0155","series-title":"Prevention of Hepatitis A Through Active or Passive Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP), Morbidity and Mortality Weekly Report: Recommendations and Reports","volume":"55(7)","author":"Fiore","year":"2006"},{"issue":"9","key":"10.1016\/j.ijbiomac.2020.02.287_bb0160","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/dna.2009.0977","article-title":"Comparison of adjuvant efficacy of chitosan and aluminum hydroxide for intraperitoneally administered inactivated influenza H5N1 vaccine","volume":"29","author":"Chang","year":"2010","journal-title":"DNA Cell Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.02.287_bb0165","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/1471-2334-14-195","article-title":"An adjuvanted inactivated murine cytomegalovirus (MCMV) vaccine induces potent and long-term protective immunity against a lethal challenge with virulent MCMV","volume":"14","author":"Wang","year":"2014","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.02.287_bb0170","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1988.tb00739.x","article-title":"The role of helper T cell products in mouse B cell differentiation and isotype regulation","volume":"102","author":"Coffman","year":"1988","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.ijbiomac.2020.02.287_bb0175","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0020-2452(97)86016-2","article-title":"Th1 and Th2 subsets of T lymphocytes: characteristics, physiological role and regulation","volume":"94","author":"Sedlik","year":"1996","journal-title":"Bulletin de l'Institut Pasteur"},{"issue":"3","key":"10.1016\/j.ijbiomac.2020.02.287_bb0180","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0167-5699(96)80606-2","article-title":"The expanding universe of T-cell subsets: Th1, Th2 and more","volume":"17","author":"Mosmann","year":"1996","journal-title":"Immunol. Today"},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.02.287_bb0185","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1081-1206(10)62426-X","article-title":"T-cell subsets (Th1 versus Th2)","volume":"85","author":"Romagnani","year":"2000","journal-title":"Annals of Allergy, Asthma & Immunology: Official Publication of the American College of Allergy, Asthma, & Immunology"},{"issue":"6179","key":"10.1016\/j.ijbiomac.2020.02.287_bb0190","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/334255a0","article-title":"Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells","volume":"334","author":"Stevens","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2020.02.287_bb0195","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cis.2014.03.009","article-title":"Preparation methods of alginate nanoparticles","volume":"209","author":"Paques","year":"2014","journal-title":"Adv. Colloid Interf. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.02.287_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23020229","article-title":"Chemical modification of chitosan for efficient vaccine delivery","volume":"23","author":"Xing","year":"2018","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.02.287_bb0205","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2672.2010.04663.x","article-title":"Isoelectric points of viruses","volume":"109","author":"Michen","year":"2010","journal-title":"J. Appl. Microbiol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.02.287_bb0210","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1586\/14760584.2015.956729","article-title":"Chitosan-based vaccine adjuvants: incomplete characterization complicates preclinical and clinical evaluation","volume":"14","author":"Vasiliev","year":"2015","journal-title":"Expert Review of Vaccines"},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.02.287_bb0215","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0144-8617(01)00212-0","article-title":"Drug release from chitosan\u2013alginate complex beads reinforced by a naturally occurring cross-linking agent","volume":"48","author":"Mi","year":"2002","journal-title":"Carbohydr. Polym."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813020305390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813020305390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:05:37Z","timestamp":1758873937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813020305390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":43,"alternative-id":["S0141813020305390"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.02.287","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alginate-coated chitosan nanoparticles act as effective adjuvant for hepatitis A vaccine in mice","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.02.287","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}